• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Ranjana H. Advani, Stephen M Ansell, +12 authors Julie M Vose
  • Medicine
  • British journal of haematology
  • 2016 (First Published: 1 February 2016)
  • Peripheral T-cell lymphomas (PTCL) have suboptimal outcomes using conventional CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy. The anti-folate pralatrexate, the first drugContinue Reading
  • Kenneth R. Carson, Peter A Riedell, +13 authors Graham A. Colditz
  • Medicine
  • Journal of geriatric oncology
  • 2015 (First Published: 1 May 2015)
  • OBJECTIVES While anthracycline-based treatment can cure diffuse large B-cell lymphoma, most patients over age 80 do not receive doxorubicin due to toxicity concerns. This study evaluated thisContinue Reading
  • Tzu-Fei Wang, Rohan Ahluwalia, +9 authors Ravi Vij
  • Medicine
  • Leukemia & lymphoma
  • 2014 (First Published: 1 February 2014)
  • Patients with multiple myeloma who are refractory or intolerant to both bortezomib and lenalidomide have a poor prognosis. Next-generation therapies carfilzomib and pomalidomide have shown promisingContinue Reading
  • Amanda F. Saltzman, Suhong Luo, Jeffery F Scherrer, Kenneth R. Carson, Robert L. Grubb, M'liss A Hudson
  • Medicine
  • Urologic oncology
  • 2015 (First Published: 1 July 2015)
  • BACKGROUND To determine whether prostate-specific antigen (PSA) testing in African American veterans (AAVs) aged 40 to 54 years is associated with high-risk prostate cancer characteristics comparedContinue Reading
  • Kenneth R. Carson, Francine M. Foss, +7 authors Eric D. Hsi
  • Medicine
  • Clinical advances in hematology & oncology : H&O
  • 2013 (First Published: 15 November 2013)
  • Background COMPLETE is a national registry of PTCL patients designed to describe patient characteristics, treatments and outcomes in a ‘real world’ setting. Previous work has suggested that there mayContinue Reading
  • Massimo Federico, Monica Bellei, +22 authors Ranjana Hira Advani
  • Medicine
  • British journal of haematology
  • 2018 (First Published: 1 June 2018)
  • Different models to investigate the prognosis of peripheral T cell lymphoma not otherwise specified (PTCL-NOS) have been developed by means of retrospective analyses. Here we report on a new modelContinue Reading